| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0167-4781(90)90024-V |
| P698 | PubMed publication ID | 1688712 |
| P2093 | author name string | R Pohlmann | |
| P Vihko | |||
| M Kontturi | |||
| T Solin | |||
| P2860 | cites work | A human cell line from a pleural effusion derived from a breast carcinoma | Q34207627 |
| Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture | Q40512568 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 72-77 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses | |
| P478 | volume | 1048 |
| Q38017593 | A molecular description of acid phosphatase |
| Q37323041 | A novel role of Shc adaptor proteins in steroid hormone-regulated cancers. |
| Q61195803 | Advances in immunotherapyfor prostate cancer |
| Q46884498 | Adverse Events in Cancer Immunotherapy |
| Q43612386 | Avian prostatic acid phosphatase: estrogen regulation in the oviduct and epithelial cell-derived ovarian carcinomas. |
| Q39149824 | Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades. |
| Q26863333 | Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor |
| Q34284652 | Dendritic Cell‐Based Immunotherapy for Prostate Cancer |
| Q37773277 | Dendritic-cell vaccination for prostate cancer |
| Q37145460 | Emerging roles of human prostatic Acid phosphatase |
| Q46942457 | Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens |
| Q44304000 | ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells |
| Q72097871 | Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern‐blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies |
| Q40371697 | Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells. |
| Q56741962 | Expression of the tumour antigen T21 is up-regulated in prostate cancer and is associated with tumour stage |
| Q36913762 | Human prostatic acid phosphatase: structure, function and regulation |
| Q44007845 | Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter |
| Q34429991 | Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy |
| Q37061769 | Immunotherapy and immune evasion in prostate cancer |
| Q36909396 | Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge). |
| Q36589866 | Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells |
| Q46126414 | Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide |
| Q54599024 | Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice. |
| Q34602552 | Prostate-specific antigen vaccines for prostate cancer |
| Q33870979 | Prostatic acid phosphatase expression in human tissues. |
| Q34324439 | Prostein expression is highly restricted to normal and malignant prostate tissues |
| Q36074603 | Rat acid phosphatase: overexpression of active, secreted enzyme by recombinant baculovirus-infected insect cells, molecular properties, and crystallization |
| Q32029050 | Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: confirmation of L7a and L37 over-expression in prostate-cancer tissue samples |
| Q36613961 | Sipuleucel-T (APC8015) for prostate cancer |
| Q30391641 | Structural and functional analysis of human prostatic acid phosphatase |
| Q34577158 | T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics |
| Q40160897 | The STEAP1(262-270) peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic mice--A new approach to immunotherapy against prostate carcinoma |
| Q45948970 | The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells |
| Q40615941 | Tissue-specific expression of the prostatic acid phosphatase promoter constructs |
| Q38339192 | Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site |
| Q41977894 | Tumor-associated antigens for specific immunotherapy of prostate cancer |
| Q44813407 | USF2 is connected to GAAAATATGATA element and associates with androgen receptor-dependent transcriptional regulation in prostate |
| Q34015848 | p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis. |
Search more.